References
- KitzmannASPulidoJSDiehlNNThe incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002Ophthalmology2008115116917318166410
- WangMMunchICHaslerPWCentral serous chorioretinopathyActa Ophthalmol200886212614517662099
- ImamuraYFujiwaraTMargolisRSpaideRFEnhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathyRetina200929101469147319898183
- JirarattanasopaPOotoSTsujikawaAAssessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathyOphthalmology201211981666167822521082
- MarukoIIidaTSuganoYSubfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathyRetina20113181603160821487334
- SpaideRFHallLHaasAIndocyanine green videoangiography of older patients with central serous chorioretinopathyRetina19961632032138789858
- IidaTKishiSHagimuraNShimizuKPersistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathyRetina199919650851210606450
- GemenetziMDe SalvoGLoteryAJCentral serous chorioretinopathy: an update on pathogenesis and treatmentEye (Lond)201024121743175620930852
- BouzasEAKaradimasPPournarasCJCentral serous chorioretinopathy and glucocorticoidsSurv Ophthalmol200247543144812431693
- Carvalho-RecchiaCAYannuzziLANegrãoSCorticosteroids and central serous chorioretinopathyOphthalmology2002109101834183712359603
- TittlMKSpaideRFWongDSystemic findings associated with central serous chorioretinopathyAm J Ophthalmol19991281636810482095
- HaimoviciRKohSGagnonDRRisk factors for central serous chorioretinopathy: a case-control studyOphthalmology2004111224424915019370
- FarmanNRafestin-OblinMEMultiple aspects of mineralocorticoid selectivityAm J Physiol Renal Physiol20012802F181F19211208593
- ZhaoMValamaneshFCelerierIThe neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Müller glial cellsFASEB J20102493405341520466875
- ZhaoMCélérierIBousquetEMineralocorticoid receptor is involved in rat and human ocular chorioretinopathyJ Clin Invest201212272672267922684104
- DelyaniJAMineralocorticoid receptor antagonists: the evolution of utility and pharmacologyKidney Int20005741408141110760075
- BousquetEBeydounTZhaoMMineralcorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot studyRetina201333102096210223719402
- GruszkaAPotential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case reportEur Rev Med Pharmacol Sci201317101369137323740451
- QuinGLiewGHoI-VDiagnosis and interventions for central serous chorioretinopathy: review and updateClin Experiment Ophthalmol201341218720022788713